No. 329-Canadian Contraception Consensus Part 4 of 4 Chapter 9: Combined Hormonal Contraception

J Obstet Gynaecol Can. 2017 Apr;39(4):229-268.e5. doi: 10.1016/j.jogc.2016.10.005.

Abstract

Objective: To provide guidelines for health care providers on the use of contraceptive methods to prevent pregnancy and on the promotion of healthy sexuality.

Outcomes: Overall efficacy of cited contraceptive methods, assessing reduction in pregnancy rate, safety, and side effects; the effect of cited contraceptive methods on sexual health and general well-being; and the availability of cited contraceptive methods in Canada.

Evidence: Medline and the Cochrane Database were searched for articles in English on subjects related to contraception, sexuality, and sexual health from January 1994 to December 2015 in order to update the Canadian Contraception Consensus published February-April 2004. Relevant Canadian government publications and position papers from appropriate health and family planning organizations were also reviewed.

Values: The quality of the evidence is rated using the criteria described in the Report of the Canadian Task Force on Preventive Health Care. Recommendations for practice are ranked according to the method described in this report.

Summary statements: RECOMMENDATIONS.

Keywords: Canada; Contraception; combined hormonal contraception; continuous hormonal contraception; emergency contraception; family planning; hormonal contraception; oral contraceptive pill; sexual health; transdermal contraceptive patch; vaginal contraceptive ring.

Publication types

  • Consensus Development Conference
  • Practice Guideline

MeSH terms

  • Body Mass Index
  • Canada
  • Contraceptives, Oral, Combined* / administration & dosage
  • Contraceptives, Oral, Combined* / adverse effects
  • Contraceptives, Oral, Combined* / pharmacokinetics
  • Contraceptives, Oral, Combined* / pharmacology
  • Contraceptives, Oral, Hormonal* / administration & dosage
  • Contraceptives, Oral, Hormonal* / adverse effects
  • Contraceptives, Oral, Hormonal* / pharmacokinetics
  • Contraceptives, Oral, Hormonal* / pharmacology
  • Contraindications, Drug
  • Female
  • Humans
  • Medication Adherence
  • Menstruation Disturbances / chemically induced
  • Myocardial Infarction / chemically induced
  • Neoplasms / chemically induced
  • Neoplasms / prevention & control
  • Patient Education as Topic
  • Pregnancy
  • Risk Factors
  • Stroke / chemically induced
  • Venous Thromboembolism / chemically induced

Substances

  • Contraceptives, Oral, Combined
  • Contraceptives, Oral, Hormonal